https://scholars.lib.ntu.edu.tw/handle/123456789/620586| Title: | Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer | Authors: | Even C. Wang H.-M. Li S.-H. Ngan R.K.-C. Dechaphunkul A. Zhang L. Yen C.-J. Chan P.C. Chakrabandhu S. Ma B.B.Y. Tanasanvimon S. Lee V.H.F. PEI-JEN LOU Li Z. Spira A.I. Sukari A. Guigay J. McCune S. Gonzalez-Maffe J. Szpakowski S. Yao Y. Liang H. Mataraza J. Sechaud R. Manenti L. Lim D.W.-T. |
Issue Date: | 2021 | Publisher: | American Association for Cancer Research Inc. | Journal Volume: | 27 | Journal Issue: | 23 | Start page/Pages: | 6413-6423 | Source: | Clinical Cancer Research | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120495726&doi=10.1158%2f1078-0432.CCR-21-0822&partnerID=40&md5=142ed4f77572b1e214cd799d072852e0 https://scholars.lib.ntu.edu.tw/handle/123456789/620586 |
ISSN: | 1078-0432 | DOI: | 10.1158/1078-0432.CCR-21-0822 | SDG/Keyword: | [SDGs]SDG3 |
| Appears in Collections: | 醫學院附設醫院 (臺大醫院) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.